博士眼镜跌2.01%，成交额1.50亿元，主力资金净流出800.29万元

Core Viewpoint - Dr. Optical's stock has experienced a significant decline this year, with a year-to-date drop of 22.22%, indicating potential challenges in the retail optical market [1][2]. Financial Performance - For the first half of 2025, Dr. Optical achieved a revenue of 686 million yuan, representing a year-on-year growth of 14.22%, while the net profit attributable to shareholders was 56.03 million yuan, up 6.97% year-on-year [2]. - The company has distributed a total of 464 million yuan in dividends since its A-share listing, with 204 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 14, Dr. Optical's stock price was 29.73 yuan per share, with a market capitalization of 6.774 billion yuan. The stock has seen a trading volume of 150 million yuan and a turnover rate of 3.20% [1]. - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) twice this year, with the most recent instance on February 21, where it recorded a net buy of -235 million yuan [1]. Shareholder Information - As of June 30, the number of shareholders for Dr. Optical increased to 53,800, a rise of 9.25% from the previous period, with an average of 2,892 circulating shares per shareholder, up 19.81% [2]. - Notable new institutional shareholders include Guangfa Innovation Upgrade Mixed Fund and Minsheng Jia Yin Continuous Growth Mixed Fund, which are now among the top ten circulating shareholders [3]. Business Overview - Dr. Optical, established on April 23, 1997, and listed on March 15, 2017, primarily engages in optical retail, with its revenue composition being 68.65% from optical glasses and fitting services, 19.47% from finished lens products, and 10.80% from contact lens products [1].